Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

816
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
816
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

651
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
651
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A Rare Presentation of Babesia-Associated Splenic Infarction in an Immunocompetent Young Male With Mild Parasitemia.

Case reports in medicine·2026
Same author

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Patient Isolates.

Antibiotics (Basel, Switzerland)·2022
Same author

Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant <i>Acinetobacter baumannii</i>: Understanding the Relationship between Microbicide and Antibiotic Resistance.

Antibiotics (Basel, Switzerland)·2022
関連記事をすべて見る

関連する実験動画

Updated: Feb 14, 2026

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
06:44

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Published on: June 23, 2009

20.4K

皮膚結核は慢性皮膚疾患として表れている.

Olivia Spina1, Henry Fraimow1,2, Justin Green1,3

  • 1Cooper Medical School of Rowan University, Camden, New Jersey, USA, rowan.edu.

Case reports in dermatological medicine
|February 13, 2026
PubMed
まとめ

皮膚結核 (CTB) の診断は,さまざまなプレゼンテーションのために困難である可能性があります. インターフェロン・ガンマ放出アッセイ (IGRA) は,この皮膚結核のパウシバシラー型を診断するのに役立ちます.

キーワード:
抗結核療法による抗結核療法ケースレポート ケースレポート皮膚結核による結核.診断 診断 診断 診断

さらに関連する動画

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
11:35

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function

Published on: December 8, 2010

17.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

関連する実験動画

Last Updated: Feb 14, 2026

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
06:44

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

Published on: June 23, 2009

20.4K
Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
11:35

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function

Published on: December 8, 2010

17.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

科学分野:

  • 皮膚科 皮膚科について
  • 感染症 感染症は感染症です.
  • 微生物学 微生物学とは

背景:

  • 皮膚結核 (Cutaneous tuberculosis,CTB) は,肺の外結核の珍しい形態である.
  • Tuberculosis verrucosa cutis (TBVC) は,パウシバキラー性であり,他の皮膚疾患に類似しているため,診断上の課題を提示しています.

研究 の 目的:

  • 皮膚結核の困難な症例において,インターフェロン・ガンマ放出アッセイ (IGRAs) の診断的有用性を強調する.
  • TBVCの管理上の困難と治療戦略について議論する.

主な方法:

  • 誤診された皮膚病変の10年間の歴史を持つ73歳の女性の症例報告.
  • 伝統的な方法 (ステイン,培養,PCR) が陰性であった場合,QuantiFERON-TB ゴールドテストを使用しました.
  • 標準的抗結核療法 (HRZE) に対する文書化された副作用.

主要な成果:

  • 陽性のQuantiFERON-TB Gold検査は,マイナスの微生物学的検査にもかかわらず,TBVCの診断を確認しました.
  • 患者はピラジナミドとリファミンピンの副作用を経験しました.
  • 代替治療のレジミンは,許容性と臨床解像度の改善につながった.

結論:

  • IGRAは,パウシバチラー性皮膚結核の診断に役立つ貴重なツールです.
  • TBVCの管理には,診断上の落とし穴に注意を払い,薬剤の副作用を慎重に検討する必要があります.
  • 個別化された治療アプローチは,TBVCの効果的な管理に不可欠です.